Haleon (NYSE:HLN) Reaches New 12-Month High at $9.49

Haleon plc (NYSE:HLN) shares hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $9.49 and last traded at $9.41, with a volume of 716214 shares changing hands. The stock had previously closed at $9.15.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. HSBC assumed coverage on shares of Haleon in a report on Wednesday, April 17th. They issued a “buy” rating on the stock. Berenberg Bank assumed coverage on shares of Haleon in a report on Wednesday, June 5th. They issued a “buy” rating on the stock. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, Haleon presently has an average rating of “Moderate Buy”.

Haleon Stock Performance

The stock has a market capitalization of $42.60 billion, a PE ratio of 30.50, a price-to-earnings-growth ratio of 2.62 and a beta of 0.24. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.53. The firm’s fifty day moving average is $8.59 and its 200-day moving average is $8.42.

Haleon (NYSE:HLN) last released its earnings results on Wednesday, May 1st. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.01. The company had revenue of $3.70 billion during the quarter, compared to the consensus estimate of $3.71 billion. Haleon had a return on equity of 13.17% and a net margin of 9.68%. As a group, research analysts anticipate that Haleon plc will post 0.47 earnings per share for the current year.

Hedge Funds Weigh In On Haleon

Institutional investors have recently bought and sold shares of the company. Clearbridge Investments LLC grew its position in shares of Haleon by 44.6% during the first quarter. Clearbridge Investments LLC now owns 38,446,978 shares of the company’s stock worth $326,415,000 after buying an additional 11,865,076 shares in the last quarter. Wellington Management Group LLP grew its position in shares of Haleon by 164.6% during the fourth quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company’s stock worth $111,454,000 after buying an additional 8,423,475 shares in the last quarter. Martin Investment Management LLC grew its position in shares of Haleon by 12,018.4% during the first quarter. Martin Investment Management LLC now owns 4,463,205 shares of the company’s stock worth $37,893,000 after buying an additional 4,426,375 shares in the last quarter. Cambiar Investors LLC acquired a new position in shares of Haleon during the fourth quarter worth about $15,225,000. Finally, Raymond James & Associates grew its position in shares of Haleon by 88.1% during the first quarter. Raymond James & Associates now owns 3,504,327 shares of the company’s stock worth $29,752,000 after buying an additional 1,641,715 shares in the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.